help button home button Am J Pathol Epitomics Buy 2 Antibodies Get 1 Free Special Offer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kosugi, T.
Right arrow Articles by Kadomatsu, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kosugi, T.
Right arrow Articles by Kadomatsu, K.
(American Journal of Pathology. 2006;168:9-19.)
© 2006 American Society for Investigative Pathology

Growth Factor Midkine Is Involved in the Pathogenesis of Diabetic Nephropathy

Tomoki Kosugi*{dagger}, Yukio Yuzawa{dagger}, Waichi Sato{dagger}, Hanayo Kawai*{dagger}, Seiichi Matsuo{dagger}, Yoshifumi Takei*, Takashi Muramatsu{ddagger} and Kenji Kadomatsu*

From the Departments of Biochemistry* and Clinical Immunology of Internal Medicine,{dagger} Nagoya University Graduate School of Medicine, Showa-ku, Nagoya, Japan; and Department of Health Science,{ddagger} Faculty of Psychological and Physical Sciences, Aichi Gakuin University, Nisshin, Japan

Diabetic nephropathy is a life-threatening disease associated with diabetes mellitus. Longstanding hyperglycemia induces pathological reactions of glomerular mesangial cells, such as overproduction of extracellular matrix, which finally lead to nephropathy. However, the mechanisms underlying its pathogenesis have not been completely elucidated. Using the Streptozotocin-induced model of diabetes, we report that mice deficient in the growth factor midkine (Mdk–/–) exhibited strikingly milder nephropathy than Mdk+/+ mice, even though both mice showed similar extents of hyperglycemia after Streptozotocin injection. Midkine expression was induced in the glomerular mesangium of Mdk+/+ mice with diabetic nephropathy and in primary cultured mesangial cells exposed to high glucose. Mdk–/– mesangial cells exhibited reduced phosphorylation of protein kinase C and extracellular signal-regulated kinase as well as reduced production of transforming growth factor-ß1 on high glucose loading. Addition of exogenous midkine restored extracellular signal-regulated kinase phosphorylation in Mdk–/– cells under high glucose conditions, whereas a midkine antisense oligodeoxynucleotide suppressed midkine in Mdk+/+ cells. Therefore, this study identifies midkine as a key molecule in diabetic nephropathy and suggests that midkine accelerates the intracellular signaling network evoked by hyperglycemia in nephropathy.




This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
T. Ozaki, C. Anas, S. Maruyama, T. Yamamoto, K. Yasuda, Y. Morita, Y. Ito, M. Gotoh, Y. Yuzawa, and S. Matsuo
Intrarenal administration of recombinant human soluble thrombomodulin ameliorates ischaemic acute renal failure
Nephrol. Dial. Transplant., January 1, 2008; 23(1): 110 - 119.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
T. Nakagawa, W. Sato, O. Glushakova, M. Heinig, T. Clarke, M. Campbell-Thompson, Y. Yuzawa, M. A. Atkinson, R. J. Johnson, and B. Croker
Diabetic Endothelial Nitric Oxide Synthase Knockout Mice Develop Advanced Diabetic Nephropathy
J. Am. Soc. Nephrol., February 1, 2007; 18(2): 539 - 550.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Society for Investigative Pathology.